Extreme discordant phenotype methodology: An intuitive approach to clinical pharmacogenetics

European Journal of Pharmacology

Volumn 410, Issue 2-3, 2000, Pages 107-120

  Nebert, Daniel W ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

DNA sequence variants; Genotype; Molecular epidemiology; Patient pair studies; Pharmacogenetic; Pharmacogenomic; Phenotype; Population genetic

Indexed keywords

DRUG;

ARTICLE; DNA SEQUENCE; DRUG PROTEIN BINDING; GENOTYPE; HUMAN; NORMAL HUMAN; PHARMACOGENETICS; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL;

ANIMALS; GENOTYPE; HUMANS; PHARMACOGENETICS; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0034723040     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00809-8     Document Type: Article

References (71)

1. Genetic disorders in children and young adults: A population study
2. α-2 macroglobulin is genetically associated with Alzheimer disease
3. Power and robustness of sib-pair linkage tests and extension to larger sibships
4. Human arylamine N-acetyltransferase genes: Isolation, chromosomal localization, and functional expression
5. HGBASE: A database of SNPs and other variations in and around human genes
6. Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat
7. Genetic determinants of drug responsiveness and drug interactions
8. Linkage analysis of quantitative trait loci: Increased power by using selected samples
9. Characterization of single-nucleotide polymorphisms in coding regions of human genes
10. Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase
11. Variations on a theme: Cataloging human DNA sequence variation
12. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis
13. PARP alleles and SLE: Failure to confirm association with disease susceptibility
14. Phenotypes of patients with "simple" Mendelian disorders are complex traits: Thresholds, modifiers, and systems dynamics
15. α-2 macroglobulin polymorphism and Alzheimer disease risk in the UK
16. Locating human quantitative trait loci: Guidelines for the selection of sibling pairs for genotyping
17. Improved inference of relationship for pairs of individuals
18. Genetic control of isoniazid metabolism in man
19. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism
20. Linkage analysis of necessary disease loci versus susceptibility loci
21. Vitamin D receptor gene polymorphisms: Analysis of ligand binding and hormone responsiveness in cultured skin fibroblasts
22. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis
23. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and mu-class glutathione S-transferase genes
24. Polymorphisms of oxidation at carbon centers of drugs and their clinical significance
25. Polymorphic human cytochrome P450 enzymes: An opportunity for individualized drug treatment
26. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat
27. Linkage disequilibrium as a gene-mapping tool
28. Interethnic factors affecting drug response
29. What is significant in whole-genome linkage disequilibrium studies?
30. Genetic isolates: Separate but equal?
31. Genetic dissection of complex traits
32. Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs
33. Sib-pair collection strategies for complex diseases
34. Prediction of bone density from vitamin D receptor alleles
35. Proposed role of drug-metabolizing enzymes: Regulation of steady-state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions
36. Polymorphisms in drug-metabolizing enzymes: What is their clinical relevance and why do they exist?
37. Pharmacogenetics: 65 candles on the cake
38. Pharmacogenetics and pharmacogenomics: Why is this relevant to the clinical geneticist?
39. Suggestions for the nomenclature of human alleles: Relevance to ecogenetics, pharmacogenetics and molecular epidemiology
40. P450 genes: Structure, evolution and regulation
41. Human drug-metabolizing enzyme polymorphisms: Effects on risk of toxicity and cancer
42. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene
43. Identification of 187 single nucleotide polymorphisms (SNPs) among 41 candidate genes for ischemic heart disease in the Japanese population
44. In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility
45. Exact multipoint quantitative-trait linkage analysis in pedigrees by variance components
46. Sequence variation in the human angiotensin-converting enzyme
47. Assessing the role of HLA-linked and unlinked determinants of disease
48. Searching for genes in complex diseases: Lessons from systemic lupus erythematosus
49. The future of genetic studies of complex human diseases
50. Extreme discordant sib pairs for mapping quantitative trait loci in humans
51. Mapping quantitative trait loci with extreme discordant sib pairs: Sampling considerations
52. An α-2 macroglobulin insertion-deletion polymorphism in Alzheimer disease
53. α-2 macroglobulin gene and Alzheimer disease
54. Role of phenytoin in wound healing - A wound pharmacology perspective
55. Linkage disequilibrium mapping of complex disease: Fantasy or reality?
56. PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus
57. Letter to the editor
58. Exon-intron organization of the human multidrug-resistance protein-2 (MRP2) gene mutated in Dubin-Johnson syndrome
59. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome
60. Population choice in mapping genes for complex diseases
61. Recent progress in pharmacogenetics
62. Moderne probleme der Humangenetik
63. Identification of 142 single-nucleotide polymorphisms in 41 candidate genes for rheumatoid arthritis in the Japanese population
64. 462: Assessment of a role for the rare allele in carcinogenesis
65. Localization of a small genomic region associated with elevated ACE